Inhibition of monoamine oxidase B by N-methyl-2-phenylmaleimides

被引:16
|
作者
Manley-King, Clarina I. [1 ]
Terre'Blanche, Gisella [1 ]
Castagnoli, Neal, Jr. [2 ,3 ]
Bergh, Jacobus J. [1 ]
Petzer, Jacobus P. [1 ]
机构
[1] North West Univ, Sch Pharm, ZA-2520 Potchefstroom, South Africa
[2] Virginia Tech, Dept Chem, Blacksburg, VA 24061 USA
[3] Edward Via Coll Osteopath Med, Blacksburg, VA 24061 USA
基金
新加坡国家研究基金会; 英国医学研究理事会;
关键词
Monoamine oxidase B; Reversible inhibitors; Competitive inhibition; Maleimide; Hydrolysis; SPECIES-DEPENDENT DIFFERENCES; ANALOGS; HYDROLYSIS; CYSTEINE;
D O I
10.1016/j.bmc.2009.03.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Based on a recent report that 1-methyl-3-phenylpyrrolyl analogues are moderately potent reversible inhibitors of the enzyme monoamine oxidase B (MAO-B), a series of structurally related N-methyl-2-phenylmaleimidyl analogues has been prepared and evaluated as inhibitors of MAO-B. In general, the maleimides were more potent competitive inhibitors than the corresponding pyrrolyl analogues. N-Methyl-2-phenylmaleimide was found to be the most potent inhibitor with an enzyme-inhibitor dissociation constant (K-i value) of 3.49 mu M, approximately 30-fold more potent than 1-methyl-3-phenylpyrrole (K-i = 118 mu M). This difference in activities may be dependent upon the ability of the maleimidyl heterocyclic system to act as a hydrogen bond acceptor. This is in correspondence with literature reports which suggest that hydrogen bond formation is involved in stabilizing inhibitor-MAO-B complexes. Also reported here is a brief kinetic study of the hydrolysis of the N-methyl-2-phenylmaleimidyl analogues in aqueous solution. The findings of the inhibition studies are discussed with reference to the rate and extent of hydrolysis. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3104 / 3110
页数:7
相关论文
共 50 条
  • [1] INHIBITION OF MONOAMINE OXIDASE BY 2-METHYL-3-PIPERIDINOPYRAZINE
    DUBNICK, B
    PHILLIPS, GE
    MORGAN, DF
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1963, 107 (03) : 914 - &
  • [2] Inhibition of monoamine oxidase B in the brains of smokers
    Fowler, JS
    Volkow, ND
    Wang, GJ
    Pappas, N
    Logan, J
    MacGregor, R
    Alexoff, D
    Shea, C
    Schlyer, D
    Wolf, AP
    Warner, D
    Zezulkova, I
    Cilento, R
    [J]. NATURE, 1996, 379 (6567) : 733 - 736
  • [4] INHIBITION OF TYPE-A MONOAMINE-OXIDASE BY 2(N)-METHYL-6,7-DIHYDROXYISOQUINOLINIUM IONS
    NAOI, M
    MARUYAMA, W
    SASUGA, S
    DENG, YL
    DOSTERT, P
    OHTA, S
    TAKAHASHI, T
    [J]. NEUROCHEMISTRY INTERNATIONAL, 1994, 25 (05) : 475 - 481
  • [5] INHIBITION OF MONOAMINE OXIDASE-A AND OXIDASE-B BY 2-PROPYNYLAMINE DERIVATIVES
    SHATEMIROVA, KK
    VERYOVKINA, IV
    GORKIN, VZ
    [J]. VOPROSY MEDITSINSKOI KHIMII, 1977, 23 (02): : 220 - 226
  • [6] Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats
    Guillem, Karine
    Vouillac, Caroline
    Azar, Marc R.
    Parsons, Loren H.
    Koob, George F.
    Cador, Martine
    Stinus, Luis
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2006, 24 (12) : 3532 - 3540
  • [7] MONOAMINE OXIDASE INHIBITION
    ROSENBLUM, I
    FERGUSON, FC
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1960, 1 (06) : 692 - 693
  • [8] Inhibition of platelet monoamine oxidase type B by selegiline
    Heinonen, EH
    Anttila, MI
    Nyman, LM
    Pyykko, KA
    Vuorinen, JA
    Lammintausta, RAS
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (07): : 597 - 601
  • [9] N-METHYL-N-2-PROPYNYL-1-INDANAMINE . A POTENT MONOAMINE OXIDASE INHIBITOR
    HUEBNER, CF
    DONOGHUE, EM
    PLUMMER, AJ
    FURNESS, PA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1966, 9 (06) : 830 - &
  • [10] Inhibition of monoamine oxidase B by selective adenosine A2A receptor antagonists
    Petzer, JP
    Steyn, S
    Castagnoli, KP
    Chen, JF
    Schwarzschild, MA
    Van der Schyf, CJ
    Castagnoli, N
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (07) : 1299 - 1310